MorphoSys AG engages in the development of therapeutic antibodies to cure inflammatory and autoimmune diseases, as well as cancer and infectious diseases. The company operates through two business segments; Partnered Discovery and Proprietary Development. This is an ADR of a company whose stock trades outside of the U.S. as the symbol GF:MOR.
$5.24 0.00 (0.00%)
As of 05/23/2022 11:56:19 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.